Discover how innovative cell culture membrane inserts from Greiner Bio-One are revolutionizing drug development. In this article Philipp Wachter explains their role in enhance high-throughput screening studies and optimizing ADME studies for better drug evaluation.
Quick decisions in blood collection are a daily challenge in healthcare. In this article we supports you in making the best possible product decisions for various patient needs.
Animal models are costly, time-consuming, and often have limited relevance to human biology. In this article, we’ll explain the advantages of magnetic 3D cell culture (M3D), why they are so useful, and how they are used in the laboratory – step-by-step.
Greiner Bio-One sets new standards in sustainability and transparency: The company's serological pipettes have been awarded the ACT ecolabel.
Kremsmünster, April 17, 2024 – Corinna Mitterschiffthaler took over the position of Director Division Human Resources at Greiner Bio-One on 2 April,…
Your leading global partner in the fields of biotechnology, diagnostics, medical devices, in vitro diagnostics as well as in the world of research. Greiner Bio-One International GmbH is a global player with more than 2300 employees and 28 subsidiaries. We have production sites in Austria, Germany, Hungary, the United States, Brazil and Thailand. The headquarters of the public limited company, which is wholly owned by the Greiner family, is in Kremsmünster, Upper Austria. Greiner Bio-One International is a company of the Greiner Group. Our focus is on a strong customer orientation and innovative, top quality product solutions.
Would you like to stay on this page or do you want to switch to your local website?
